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Background: Associations between transcription factor 7-like 2 (TCF7L2) polymorphisms and type 2 diabetes
mellitus (T2DM) have been evaluated extensively in multiple ethnic groups. TCF7L2 has emerged as the strongest
T2DM susceptibility gene in Europeans, but the findings have been inconsistent in the Chinese population. The
purpose of this meta-analysis was to evaluate the associations between TCF7L2 single nucleotide polymorphisms
(SNPs) and T2DM risk in the Chinese population.
Methods: We performed searches in the PubMed, EMBASE, Cochrane, and Chinese databases (CNKI, CQVIP and
Wanfang databases) for literature published from January 2007 to February 2012. We reviewed all relevant articles
on TCF7L2 polymorphisms and susceptibility to T2DM in the Chinese population written in English and Chinese.
Two reviewers extracted data independently using a standardized protocol, and any discrepancies were adjudicated
by a third reviewer. Fixed-effects and random-effects meta-analyses were performed to pool the odds ratios (ORs).
Publication bias and heterogeneity were examined.
Results: A total of 21 articles were confirmed to be eligible for and included in this meta-analysis: 7 (with 3942
cases and 3502 controls) concerning rs11196218 (IVS−/+4G>A), 8 (with 3377 cases and 2975 controls) concerning
rs290487 (IVS3−/+C>T), and 14 (with 7902 cases and 7436 controls) concerning rs7903146 (IVS3−/+C>T). Overall,
the results showed a significant association between rs7903146 and T2DM risk. The pooled ORs were 1.54 for the
comparison of T and C alleles (95% CI [confidence interval]: 1.37–1.74, p = 1.47 × 10-12, I2 = 25.20%) and 1.56 for TC
heterozygotes and CC homozygotes (95% CI : 1.38–1.76, p = 8.25 × 10-9, I2 = 21.00%). The rs11196218(IVS4G>A) and
rs290487 (IVS3C>T) SNPs were not associated with T2DM risk.
Conclusions: The rs7903146 SNP of the TCF7L2 gene is associated with increased susceptibility to T2DM in the
Chinese population as a whole as well as northern Chinese and southern Chinese as subgroups.
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Type 2 diabetes mellitus (T2DM) is the most common
form of diabetes, accounting for 90% of cases in the
world [1]. The incidence and prevalence of T2DM has
reached epidemic proportions worldwide. It is estimated
that China will contribute almost 38 million patients to
the global burden of diabetes by 2025 [2,3]. Moreover,
the incidence of T2DM in children has increased dra-
matically in the past decades [4]. Although T2DM
pathogenesis remains to be fully elucidated, genetic sus-
ceptibility appears to play a crucial role in the etiology
and manifestation of the disease [5-7]. Notably, single
nucleotide polymorphisms (SNPs) of the transcription
factor 7-like 2 (TCF7L2) gene have been reported to
affect T2DM susceptibility by indirectly altering expres-
sion of GLP-1 [8], which in addition to insulin, plays a
critical role in blood glucose homeostasis [9].
In recent years, numerous studies examining various
ethnic groups have demonstrated an association between
TCF7L2 genotype and T2DM. However, the results have
been inconsistent [10-30]. Five meta-analyses of the
association between TCF7L2 SNPs and T2DM have been
published [31-35]. The first published in 2007, demon-
strated a significant association between the rs7903146
SNP and T2DM in Moroccans (allelic OR = 1.56, 95% CI
[confidence interval]: 1.29 – 1.89, p = 2.9 × 10-6) and Aus-
trians (allelic OR = 1.52, 95% CI: 1.29–1.78, p = 3.0 × 10-7)
[33]. The second study published in 2009, demonstrated
significant associations between four TCF7L2 SNPs
(rs7903146, rs12255372, rs7901695 and rs11196205) and
T2DM [32]; however, only two articles examining Chinese
subjects were included in that meta-analysis. The third
meta-analysis, also published in 2009 but which included
six studies of Chinese population samples, concluded that
there were five TCF7L2 SNPs (rs7903146, rs12255372,
rs11196205, rs290487 and rs11196218) associated with
T2DM risk among East-Asian people [31]. The fourth
study, also published in 2009, focused on differences in the
association between rs7903146 and T2DM among differ-
ent inter-East Asian populations; three of the six studies
had examined Chinese population samples [34]. The fifth
study was a three-stage analysis designed to identify sus-
ceptibility loci for T2DM among East Asians. In the first
stage, the researchers performed a meta-analysis of eight
T2DM genome-wide association studies (6952 cases and
11,865 controls) for established T2DM risk loci and con-
firmed a significant association between rs7903146 and
T2DM risk among East-Asians (OR = 1.16, 95% CI: 1.02–
1.31, p = 2.5 × 10-2) [35]; however, none of those eight
studies examined Chinese people.
Sixteen studies [14,15,18-30] examining this question in
Chinese population samples have been published since the
aforementioned meta-analyses. However, their results have
been inconsistent. Thus, the potential association betweenTCF7L2 polymorphisms and T2DM in Chinese popula-
tion remains inconclusive. In this study, we performed an
up-to-date meta-analysis to assess the contribution of
TCF7L2 polymorphisms to T2DM susceptibility specific-
ally in Chinese people.
Methods
Primary search strategy
We conducted a search of the PubMed, EMBASE,
Cochrane, and Chinese literature databases (CNKI,
CQVIP, and Wanfang databases) for articles published
from January 2007 to February 2012. The following
subject terms were used: ‘TCF7L2’, ‘genetic polymorphism’,
‘Chinese’, and ‘T2D/T2DM’. Only human studies pub-
lished in English or Chinese were retrieved for consider-
ation. The reference lists of the selected articles were
searched to identify any additional relevant articles.
Inclusion criteria and data extraction
Studies were selected for our analysis if they reported
the genotype or allele frequencies of TCF7L2 poly-
morphisms in Chinese T2D patients and controls. Data
were extracted by two reviewers (J. Wang and F. Hu)
using a standardized data extraction form. Discrepancies
were adjudicated by the third reviewer (L. Li) until a
consensus was achieved on each item. A total of 21 eli-
gible articles were included in the meta-analysis.
Statistical analysis
The Metan module in the STATA 11.0 software package
was used to perform the meta-analysis on genotype fre-
quencies. The strength of the association between each
SNP and T2DM risk was measured by determining ORs
with 95% CIs. The Z test was used to determine the stat-
istical significance of pooled ORs. Heterogeneity index
(I2, 0–100) was applied to assess heterogeneity among
the studies [36]. In accordance with the Cochrane
reviewer’s handbook 4.2.2 [37], we accepted a high de-
gree of heterogeneity for study pairs with an I2>50%.
When heterogeneity was not an issue, the fixed effects
model was applied with the Mantel-Haenszel method
[38]. Otherwise, a random effects model was applied
using the DerSimonian and Laird method to calculate
the combined OR [39]. Subgroup analyses were per-
formed by region (South or North) for each SNP.
Non-risk and risk alleles were represented by A1 and
A2, respectively. The OR for the risk allele A2, A1/A2
was compared to that for A1/A1, and the OR for A2/A2
was compared to for A1/A1.
The present meta-analysis evaluated the association
between three SNPs in TCF7L2 gene and T2D, and the
Bonferroni method [40] was employed to adjust for Type
I errors. Specifically, the Bonferroni significance thresh-
old was set at α = 0.05 / 3 = 0.017 for the 3 SNPs.
Figure 1 LD plots for rs7903146, rs11196218, and rs290487 in
the Chinese population. Based on Hapmap data (HapMap Data Rel
27 PhaseII+III, Feb09, on NCBI B36 assembly, dbSNP b126).
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[41]. Furthermore, Egger’s regression approach was
adopted [42]. Power calculation was performed using
PASS ( Power analysis and sample size, by Jerry) soft-
ware. Population-attributable risk (PAR) was calculated
based on the estimated ORs and risk allele frequencies
of those SNPs that showed significant association with
T2DM risk.
Results
Inclusion of SNPs for analysis
Among SNPs previously associated with T2DM risk in the
Chinese population, only three were adequately repre-
sented in the selected literature and had sufficient low
minor allele frequency (MAF) to be included in our meta-
analysis: rs7903146, rs11196218, and rs290487. We found
that Hapmap data (HapMap Data Rel 27 Phase II+III,
Feb09, on NCBI B36 assembly, dbSNP b126) indicate that,
in the Chinese population, the linked disequilibrium (LD)
structure places D’ at 1.0 unit between rs7903146 and
rs290487, 1.0 unit between rs7903146 and rs11196218,
and 0.059 unit between rs290487 and rs11196218
(Figure 1). Between rs7903146 and rs11196218, r2 =
0.016, between rs7903146 and rs290487, r2 =0.013, and
between rs11196218 and rs290487, r2 = 0.001 (see
Additional file 1: Table S1). The LD was relatively low
among three SNPs in the Chinese population, so we
decided to include these SNPs in our meta-analysis.
Characteristics of included studies
Of 38 studies were identified as the potential candidates,
21 were deemed eligible for the final meta-analysis
[10-30]; these 21 articles examined the three included
at least one of the SNPs noted above (rs7903146,
rs11196218, and rs290487). As reported in detail
Additional file 1: Table S2, we examined seven studies
(total of 3942 cases and 3502 controls) related to
rs11196218 (ISV4−/+G>A), eight studies (total of
3377 cases and 2975 controls) related to rs290487
(ISV3−/+C>T), and fourteen studies (total of 7902
cases and 7436 controls) related to rs7903146 (ISV3
−/+C>T). Our examination of heterogeneity among stud-
ies (see Additional file 1: Table S3) revealed a high
heterogeneity among studies for rs11196218 and
rs290487. As shown in Figure 2 and Additional file 1:
Table S4, both Egger’s and Begg’s tests suggested
no publication bias in the associations between
rs11196218, rs290487, and rs7903146 and risk of
T2DM.
Results of meta-analysis
The detailed results of our meta-analysis are
reported in Additional file 1: Table S3. Notably, we
obtained highly significant ORs for rs7903146,including the pooled OR for the T allele versus the
C allele (OR = 1.54, 95% CI: 1.37–1.74, p = 1.47 × 10-12,
I2 = 25.20%) and the OR for heterozygotes versus C
homozygotes (OR = 1.56, 95% CI: 1.38–1.76, p = 8.25 ×
10-9, I2 = 21.00%) (Figure 3). The population attributable
risk (PAR) was 1.6% for the risk allele T and 2.9% for CT
genotype of rs7903146. We did not find significant asso-
ciations between the risk alleles for rs11196218 and
rs290487 and risk for T2DM.
Results of the subgroup analyses
When people from the northern and southern regions of
China were each considered independently, we found
that the allele and genotype of rs7903146 ORs remained
significant for both subgroups (see Additional file 1:
Table S3). In addition, we found that for rs290487 the
pooled OR in subgroup analysis based on the region was
Figure 2 Funnel plot for rs7903146. Panel A: the ORs of allele T versus allele C of rs7903146 overall; Panel B: of the ORs of heterozygotes
versus C homozygotes of rs7903146 overall.
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the southern region of China.
Sensitivity analysis
The sensitivity analysis was performed by omitting one
study at a time. None of the individual studies influ-
enced the final conclusions for rs290487. Likewise, re-
moval of studies did not affect the conclusion for the
risk allele A and the A homozygotes versus G homozy-
gotes comparison for rs11196218, nor the conclusions
for the risk allele T and the heterozygotes versus C
homozygotes comparison for rs7903146. However, when
Ying Zhang et al.’s study [24] was omitted, we found that
the comparison for heterozygotes versus G homozygotes
of rs11196218, which previously had a p value of 0.15,became significant (OR = 0.87, 95% CI : 0.78–0.97, p =
0.010, I2 = 47.80%).
Discussions
In this study, we evaluated the effects of three well-
known SNPs of the TCF7L2 gene (rs11196218, rs290487,
and rs7903146) on the susceptibility for T2DM among
Chinese people by reviewing 21 eligible articles. It
should be noted that these three SNPs are located in the
splicing sites, and thus may affect exons and introns
splicing. Our meta-analysis confirmed a significant asso-
ciation between the risk allele in rs7903146 (T) and risk
of T2DM in the whole Chinese people regardless of
region diversity. When considering the Chinese popula-
tion as a whole, our data did not support significant
Figure 3 Forest plots for rs7903146. For the association between the T and C alleles of rs7903146 and risk of T2DM (A, OR = 1.54, 95% CI:
1.37–1.74, p = 1.47 × 10-12, I2 = 25.20%), and for the association between rs7903146 heterozygotes and C homozygotes and risk of T2DM
(B, OR = 1.56, 95% CI: 1.34–1.76, p = 8.25 × 10-9, I2 = 21.00%).
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contrasts with former results form Luo et al’s meta-
analysis of studies involving East Asians [31], which
showed a combined allelic odds radio for rs290487 (OR =
1.11, 95% CI : 1.03–1.19, p = 0.01). This difference may be
due to difference in the populations considered given that
the present analysis was focused on studies of Chinesepeople, while Japanese participants were highly repre-
sented in the former study (62.5% for rs290487). Indeed,
as shown in Additional file 1: Table S5 which summarizes
the MAFs for Chinese, Japanese, and European popula-
tions, MAFs are not uniform across populations (see
Additional file 1: Table S5). Specifically, relative to Chinese
population, Japanese population have lower MAF for
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land China). The present meta-analysis had weak power
(only 9.4%, 6.1% and 9.9% power to detect associations of
risk allele, CT genotype and CC genotype of rs290487) for
detecting associations between rs290487 risk allele or
genotype with T2DM risk (see Additional file 1: Table S6).
The significant associations between the rs7903146
SNP in TCF7L2 and T2DM risk found in our study were
similar to the findings of a large study (1529 cases and
1439 controls) by Xin Tang et al. in China [25], but con-
trast with some small sample studies [21,23]. It could be
that the small sample studies lacked sufficient statistical
power to reveal these associations.
The present results also differ from those Takeuchi
et al.’s meta-analysis published in 2009 [34] that focused
on the ethnic differences across inter-East Asian popula-
tions in that Takeuchi et al.’s combined OR for rs7903146
among Chinese people did not emerge as significant
(OR = 1.21, 95% CI : 0.96–1.51, p = 0.12 ). This dif-
ference is likely due to the fact that in addition to the
three Chinese studies included in their meta-analysis, 12
new papers were included in our analysis.
The results in our meta-analysis regarding the rs7903146
risk allele T and genotype CT were similar to those
reported in 2009 by Tong et al. [32] who examined a
variety of ethnic groups including Caucasians, North
Europeans, East Asians, Indians, Africans, and others.
However, our genotype TT finding differed from Tong
et al.’s results. Given the ethnically broad inclusion of
Tong et al’s study and the ethnically narrow inclusion
of ours, there are several population-related reasons
for this difference. First, the risk allele frequency in
the Chinese population is much lower than that in
Europeans (the minor allele frequencies was 0.024
and 0.035 in the Chinese and Japanese populations,
respectively; it was 0.279 in European populations,
listed in Additional file 1: Table S5. Second, there was
also a substantial difference in LD structure between
Chinese and European population (see Additional file
1: Table S1 for r2 values based on HapMap data).
These differences in genetic structure between the
Chinese and European populations may explain why
this SNP produced different results between studies
involving different ethnic groups. Due to the lower
MAF of rs7903146 in Chinese populations, the
estimated PARs for the T allele (1.7%) and the CT
genotype (3.2%) were much lower in our analysis
than the PARs reported for populations of European
ancestry (17–28%) [43].
When we separated northern Chinese from southern
Chinese, the pattern of our risk results changed for
rs290487. Specifically, when southern Chinese subjects
were analyzed separatedly, we obtained significant OR for
the C homozygotes versus T homozygotes comparison forrs290487, pointing to an increased T2DM risk for C
homozygotes.
Heterogeneity is a potential problem when interpreting
the results of meta-analyses [44]. In our meta-analysis,
high heterogeneity persisted in studies examining asso-
ciations between the rs290487 the rs11196218 SNPs and
T2DM risk. Because our subject pool was limited en-
tirely to mainland Chinese persons, the ethnic hetero-
geneity of our study was limited. In our subgroup
analysis, heterogeneity was not reduced for either of
the regional subgroups. Nevertheless, gender and age
likely contributed to the heterogeneity of our study
population.
Violations of the Hardy-Weinberg assumptions can
cause deviations from expectation due to improper sam-
pling. The genotypes of both cases and controls did not
deviate significantly from the Hardy-Weinberg equilib-
rium in any of the 21 reported deemed eligible for inclu-
sion in our study.
Pooling risk estimates from multiple studies can in-
crease statistical power. To our knowledge, our meta-
analysis is the largest such study of this question select-
ively involving Chinese subjects. However, there are se-
veral limitations inherent in performing a meta-analysis
of this kind that shoud be noted. First, due to the lower
MAF of some TCF7L2 SNPs in the Chinese population,
the literature examing the relationship between these
SNPs and T2DM in Chinese subjects specifically is rela-
tively limited. Second, the sample sizes of some of the
included studies were relatively small. Third, since our
analysis involves previously published source data, the
extent of our evalystion of potential interactions of these
SNPs with T2DM is limited. Finally, given the lack of full
information about gender and age of the subjects across
the studies, it was not possible to perform a stratified
analysis or interaction analysis based on age or gender.
Conclusions
The rs7903146 SNP of the TCF7L2 gene is associated
with increased susceptibility to T2DM in the Chinese
population as a whole as well as northern Chinese and
southern Chinese as subgroups.
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meta-analysis for TCF7L2 polymorphisms and the T2DM susceptibility.
Table S4. Results of Egger’s test. Table S5. MAFs for the three presently
examined SNPs analyzed in the Chinese, Japanese, and European
populations. Table S6. Power calculation for the present meta-analysis.
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